These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 117654)

  • 21. Isolation and molecular size of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Appl Environ Microbiol; 1977 Feb; 33(2):400-5. PubMed ID: 403861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Ohyama T
    Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hemagglutinin of Clostridium botulinum. Extraction, chemical characteristics and serologic specificity].
    Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):14-8. PubMed ID: 47673
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemical characterization of cell wall protein antigen purified from the cell wall autolysate of Clostridium botulinum type A.
    Takumi K; Kawata T
    Jpn J Microbiol; 1975 Feb; 19(1):1-6. PubMed ID: 51110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Production of a homogeneous Cl. botulinum type B neurotoxin].
    Saprykina TP; Kliucheva VV; Blagoveshchenskiĭ VA; Mironova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):86-91. PubMed ID: 6778041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and crystallization of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Jpn J Vet Res; 1972 Jun; 20(1):19-30. PubMed ID: 4628910
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparative isolation and immunochemical study of the O- and H-antigen components of Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):51-8. PubMed ID: 4986278
    [No Abstract]   [Full Text] [Related]  

  • 32. Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.
    Sugiyama H; Moberg LJ; Messer SL
    Appl Environ Microbiol; 1977 Apr; 33(4):963-6. PubMed ID: 405926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemagglutinin specificity of Cl. botulinum types A, B, and F in reaction with erythrocytes of various animals].
    Blagoveshchenskii BA; Ivanova LG; Khatuntseva NV; Kliucheva VV; Nikitina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jul; (7):47-51. PubMed ID: 56111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody to type F Clostridium botulinum toxin.
    Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
    Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
    Ohishi I; Okada Y
    J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.